Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-08

FDA Approved: CYCLOSERINE — Supplemental Application (Dr. Reddys Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cycloserine from Dr. Reddy's Laboratories, Inc. (ANDA 060593).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cycloserine (cycloserine)

Snippet

SUPPL AP for CYCLOSERINE (CYCLOSERINE)